1,367
Views
2
CrossRef citations to date
0
Altmetric
Coronavirus – Research Article

The effect of COVID-19 vaccination on epileptic seizures in patients with epilepsy: A clinical observation in China

, , , , , & ORCID Icon show all
Article: 2141519 | Received 13 Aug 2022, Accepted 26 Oct 2022, Published online: 22 Nov 2022

References

  • World Health Organization. WHO coronavirus (COVID-19) dashboard with vaccination data. https://covid19.who.int.2022-06-08.
  • Jalkanen P, Kolehmainen P, Häkkinen HK, Huttunen M, Tähtinen PA, Lundberg R, Maljanen S, Reinholm A, Tauriainen S, Pakkanen SH, et al. COVID-19 mRNA vaccine induced antibody responses against three SARS-CoV-2 variants. Nat Commun. 2021;12(1):1. doi:10.1038/s41467-021-24285-4.
  • Wang X, Zhao X, Song J, Wu J, Zhu Y, Li M, Cui Y, Chen Y, Yang L, Liu J, et al. Homologous or heterologous booster of inactivated vaccine reduces SARS-CoV-2 Omicron variant escape from neutralizing antibodies. Emerging Microbes Infect. 2022;11(1):477–7. doi:10.1080/22221751.2022.2030200.
  • Zeng B, Gao L, Zhou Q, Yu K, Sun F. Effectiveness of COVID-19 vaccines against SARS-CoV-2 variants of concern: a systematic review and meta-analysis. BMC Med. 2022;20(1):1–15. doi:10.1186/s12916-022-02397-y.
  • Lauring AS, Tenforde MW, Chappell JD, Gaglani M, Ginde AA, McNeal T, Ghamande S, Douin DJ, Talbot HK, Casey JD, et al. Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study. BMJ (Clin Res Ed). 2022;376:e069761. doi:10.1136/bmj-2021-069761.
  • Cabezudo-García P, Ciano-Petersen NL, Mena-Vázquez N, Pons-Pons G, Castro-Sánchez MV, Serrano-Castro PJ. Incidence and case fatality rate of COVID-19 in patients with active epilepsy. Neurology. 2020;95(10):e1417–25. doi:10.1212/WNL.0000000000010033.
  • Horváth RA, Sütő Z, Cséke B, Schranz D, Darnai G, Kovács N, Janszky I, Janszky J. Epilepsy is overrepresented among young people who died from COVID-19: analysis of nationwide mortality data in Hungary. Seizure. 2022;94:136–41. doi:10.1016/j.seizure.2021;11.013.
  • Siahaan YM, Ketaren RJ, Hartoyo V, Hariyanto TI. Epilepsy and the risk of severe coronavirus disease 2019 outcomes: a systematic review, meta-analysis, and meta-regression. Epilepsy Behav. 2021;125:108437. doi:10.1016/j.yebeh.2021.108437.
  • Qiao S, Zhang R-R, Yang T-T, Wang Z-H, Fang X-Q, Fang C-Y, Geng J-H, Zhang D-M, Qu L-X, Cao L-L, et al. Attitudes to being vaccinated against COVID-19: a survey of people with epilepsy in China. Front Neurol. 2021;12:743110. doi:10.3389/fneur.2021.743110.
  • Li N, Chu C, Lin W. A survey of hesitancy and response to the COVID-19 vaccine among patients with epilepsy in northeast China. Front Neurol. 2021;12:778618. doi:10.3389/fneur.2021.778618.
  • Puteikis K, Mameniškienė R. Factors associated with COVID-19 vaccine hesitancy among people with epilepsy in Lithuania. Int J Environ Res Public Health. 2021;18(8):4374. doi:10.3390/ijerph18084374.
  • Lin K, Huang H, Fang S, Zheng G, Fu K, Liu N, Du H. Should patients with epilepsy be vaccinated against coronavirus disease 2019? A systematic review and meta-analysis. Epilepsy Behav. 2022;134:108822. doi:10.1016/j.yebeh.2022.108822.
  • von Wrede R, Pukropski J, Moskau-Hartmann S, Surges R, Baumgartner T. COVID-19 vaccination in patients with epilepsy: first experiences in a German tertiary epilepsy center. Epilepsy Behav. 2021;122:108160. doi:10.1016/j.yebeh.2021.108160.
  • Massoud F, Ahmad SF, Hassan AM, Alexander KJ, Al–hashel J, Arabi M. Safety and tolerability of the novel 2019 coronavirus disease (COVID-19) vaccines among people with epilepsy (PWE): a cross-sectional study[j]. Seizure. 2021;92:2–9. doi:10.1016/j.seizure.2021.08.001.
  • Özdemir HN, Dere B, Gökçay F, Gökçay A. Are COVID-19 vaccines safe for people with epilepsy? A cross-sectional study. Neurol Sci. 2022;43(6):3489–96. doi:10.1007/s10072-022-05956-6.
  • Lu L, Zhang Q, Xiao J, Zhang Y, Peng W, Han X, Chen S, Yang D, Sander JW, Zhou D, et al. COVID-19 vaccine take-up rate and safety in adults with epilepsy: data from a multicenter study in China. Epilepsia. 2022;63(1):244–51. doi:10.1111/epi.17138.
  • International League against epilepsy. COVID-19 vaccines and people with epilepsy; ( Updated: 2022 Feb 21). https://www.Ilae.org/patient-care/covid-19-and-epilepsy/covid-19-vaccines-and-people-with-epilepsy.
  • Department of Health & Social Care of UK. Independent report. Joint committee on vaccination and immunization: advice on priority groups for COVID-19 vaccination. 2020 Dec 30. https://www.gov.uk/government/publications/priority-groups-for-coronavirus-covid-19-vaccination-advice-from-the-jcvi-30-december-2020/joint-committee-on-vaccination-and-immunisation-advice-on-priority-groups-for-covid-19-vaccination-30-december-2020.2022-06-26.
  • de Picker LJ, Dias MC, Benros ME, Vai B, Branchi I, Benedetti F, Borsini A, Leza JC, Kärkkäinen H, Männikkö M, et al. Severe mental illness and European COVID-19 vaccination strategies. Lancet Psychiatry. 2021;8(5):356–59. doi:10.1016/s2215-0366(21)00046-8.
  • National Health Commission of the People’s Republic of ChinaTechnical guidelines for SARS-CoV-2 vaccination in China (1st edition). Int J Epidemiol Infect Dis. 2021;48(2):91–92. doi:10.3760/cma.j.cn331340-20210329-00061.(Chinese).
  • Fisher RS, Acevedo C, Arzimanoglou A, Bogacz A, Cross JH, Elger CE, Engel J, Forsgren L, French JA, Glynn M, et al. ILAE official report: a practical clinical definition of epilepsy. Epilepsia. 2014;55(4):475–82. doi:10.1111/epi.12550.
  • Guerrini R, Dravet C, Genton P, Belmonte A, Kaminska A, Dulac O. Lamotrigine and seizure aggravation in severe myoclonic epilepsy. Epilepsia. 1998;39(5):508–12. doi:10.1111/j.1528-1157.1998.tb01413.x.
  • Romozzi M, Rollo E, Quintieri P, Dono F, Evangelista G, Consoli S, Veleno L, Anzellotti F, Calvello C, Costa C, et al. Impact of COVID-19 vaccine on epilepsy in adult subjects: an Italian multicentric experience. Neurol Sci. 2022;43(8):4627–34. doi:10.1007/s10072-022-06100-0.
  • Berg AT, Berkovic SF, Brodie MJ, Buchhalter J, Cross JH, van Emde Boas W, Engel J, French J, Glauser TA, Mathern GW, et al. Revised terminology and concepts for organization of seizures and epilepsies: report of the ILAE commission on classification and terminology, 2005-2009. Epilepsia. 2010;51(4):676–85. doi:10.1111/j.1528-1167.2010.02522.x.
  • Fisher RS, Cross JH, French JA, Higurashi N, Hirsch E, Jansen FE, Lagae L, Moshé SL, Peltola J, Roulet Perez E, et al. Operational classification of seizure types by the international league against epilepsy: position paper of the ILAE commission for classification and terminology. Epilepsia. 2017;58(4):522–30. doi:10.1111/epi.13670.
  • Kwan P, Arzimanoglou A, Berg AT, Brodie MJ, Allen Hauser W, Mathern G, Moshé SL, Perucca E, Wiebe S, French J. Definition of drug resistant epilepsy: consensus proposal by the ad hoc task force of the ILAE commission on therapeutic strategies. Epilepsia. 2010;51:1069–77. doi:10.1111/j.1528-1167.2009.02397.x.
  • Arnheim-Dahlström L, Hällgren J, Weibull CE, Sparén P. Risk of presentation to hospital with epileptic seizures after vaccination with monovalent AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine (Pandemrix): self controlled case series study. BMJ (Clin Res Ed). 2012;345:e7594. doi:10.1136/bmj.e7594.
  • Barlow WE, Davis RL, Glasser JW, Rhodes PH, Thompson RS, Mullooly JP, Black SB, Shinefield HR, Ward JI, Marcy SM, et al. The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccine. N Engl J Med. 2001;345(9):656–61. doi:10.1056/NEJMoa003077.
  • Patone M, Handunnetthi L, Saatci D, Pan J, Katikireddi SV, Razvi S, Hunt D, Mei XW, Dixon S, Zaccardi F, et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat Med. 2021;27(12):2144–53. doi:10.1038/s41591-021-01556-7.
  • Koh JS, Hoe RHM, Yong MH, Chiew HJ, Goh Y, Yong KP, Tu TM, Chan DWS, Tan BYQ, Yeo LLL, et al. Hospital-based observational study of neurological disorders in patients recently vaccinated with COVID-19 mRNA vaccines. J Neurol Sci. 2021;430:120030. doi:10.1016/j.jns.2021.120030.
  • Malek N, Heath CA, Greene J. A review of medication adherence in people with epilepsy. Acta Neurol Scand. 2017;135(5):507–15. doi:10.1111/ane.12703.
  • Faught E, Duh MS, Weiner JR, Guérin A, Cunnington MC. Nonadherence to antiepileptic drugs and increased mortality: findings from the RANSOM Study. Neurology. 2008;71(20):1572–78. doi:10.1212/01.wnl.0000319693.10338.b9.
  • Samsonsen C, Sand T, Bråthen G, Helde G, Brodtkorb E. The impact of sleep loss on the facilitation of seizures: a prospective case-crossover study. Epilepsy Res. 2016;127:260–66. doi:10.1016/j.eplepsyres.2016.09.014.
  • Ferlisi M, Shorvon S. Seizure precipitants (triggering factors) in patients with epilepsy. Epilepsy Behav. 2014;33:101–05. doi:10.1016/j.yebeh.2014.02.019.
  • Assenza G, Lanzone J, Brigo F, Coppola A, Di Gennaro G, Di Lazzaro V, Ricci L, Romigi A, Tombini M, Mecarelli O. Epilepsy care in the time of COVID-19 pandemic in Italy: risk factors for seizure worsening. Front Neurol. 2020;11:737. doi:10.3389/fneur.2020.00737.
  • Casassa C, Moss R, Goldenholz DM. Epilepsy during the COVID-19 pandemic lockdown: a US population survey. Epileptic Disord. 2021;23(2):257–67. doi:10.1684/epd.2021.1259.
  • China association against epilepsy community management committeePatients with epilepsy and COVID-19 vaccines: advice from Chinese experts. J Epilepsy. 2021;7(7):323–26. doi:10.1111/ane.13417.(Chinese).